Tami Tillotson Martin - Net Worth and Insider Trading

Tami Tillotson Martin Net Worth

The estimated net worth of Tami Tillotson Martin is at least $3 Million dollars as of 2024-04-25. Tami Tillotson Martin is the Sr. V.P., Regulatory Affairs of Supernus Pharmaceuticals Inc and owns about 85,664 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $3 Million. Details can be seen in Tami Tillotson Martin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tami Tillotson Martin has not made any transactions after 2024-01-10 and currently still holds the listed stock(s).

Transaction Summary of Tami Tillotson Martin

To

Tami Tillotson Martin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tami Tillotson Martin owns 1 companies in total, including Supernus Pharmaceuticals Inc (SUPN) .

Click here to see the complete history of Tami Tillotson Martin’s form 4 insider trades.

Insider Ownership Summary of Tami Tillotson Martin

Ticker Comapny Transaction Date Type of Owner
SUPN Supernus Pharmaceuticals Inc 2024-01-10 Sr. V.P. & Regulatory Affairs

Tami Tillotson Martin Latest Holdings Summary

Tami Tillotson Martin currently owns a total of 1 stock. Tami Tillotson Martin owns 85,664 shares of Supernus Pharmaceuticals Inc (SUPN) as of January 10, 2024, with a value of $3 Million.

Latest Holdings of Tami Tillotson Martin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SUPN Supernus Pharmaceuticals Inc 2024-01-10 85,664 29.31 2,510,812

Holding Weightings of Tami Tillotson Martin


Tami Tillotson Martin Form 4 Trading Tracker

According to the SEC Form 4 filings, Tami Tillotson Martin has made a total of 6 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 8,000 shares on January 10, 2024, which brought Tami Tillotson Martin around $223,280.

Insider Trading History of Tami Tillotson Martin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tami Tillotson Martin Trading Performance

GuruFocus tracks the stock performance after each of Tami Tillotson Martin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tami Tillotson Martin is 97.82%. GuruFocus also compares Tami Tillotson Martin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tami Tillotson Martin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tami Tillotson Martin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tami Tillotson Martin

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -16.25 97.82 93.47 -13.74 15.81 30.44
Relative Return to S&P 500(%) -9.61 96.22 90.18 -31.66 -1.46 14.85

Tami Tillotson Martin Ownership Network

Ownership Network List of Tami Tillotson Martin

No Data

Ownership Network Relation of Tami Tillotson Martin


Tami Tillotson Martin Owned Company Details

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Tami Tillotson Martin is the Sr. V.P. & Regulatory Affairs of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr VP & Quality & GMP Oper. & IT Frank Mottola , and director & President & CEO Jack A. Khattar .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Tami Tillotson Martin made 3 insider transaction in Supernus Pharmaceuticals Inc (SUPN) with a net sale of 21,235. Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 116,005 shares made by Padmanabh P. Bhatt , a net sale of 76,390 shares made by Jack A. Khattar , and a net sale of 5,890 shares made by Frank Mottola .

In summary, during the past 3 months, insiders sold 98,505 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 98,505 shares. During the past 18 months, 231,113 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 231,113 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

Tami Tillotson Martin Mailing Address

Above is the net worth, insider trading, and ownership report for Tami Tillotson Martin. You might contact Tami Tillotson Martin via mailing address: C/o Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville Md 20850.

Discussions on Tami Tillotson Martin

No discussions yet.